Running Shoes Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Report ID: 1626 | Published Date: Jan 2025 | No. of Page: 159 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents
1  RESEARCH SCOPE
    1.1 Research Product Definition
    1.2 Research Segmentation
        1.2.1 Product Type
        1.2.2 Main product Type of Major Players
    1.3 Demand Overview
    1.4 Research Methodology
2 GLOBAL RUNNING SHOES INDUSTRY
    2.1 Summary about Running Shoes Industry
    2.2 Running Shoes Market Trends
        2.2.1 Running Shoes Production & Consumption Trends
        2.2.2 Running Shoes Demand Structure Trends
    2.3 Running Shoes Cost & Price
3  MARKET DYNAMICS
    3.1 Manufacturing & Purchasing Behavior in 2020
    3.2 Market Development under the Impact of COVID-19
        3.2.1 Drivers
        3.2.2 Restraints
        3.2.3 Opportunity
        3.2.4 Risk
4  GLOBAL MARKET SEGMENTATION
    4.1 Region Segmentation (2017 to 2021f)
        4.1.1 North America (U.S., Canada and Mexico)
        4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
        4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
        4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
        4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
    4.2 Product Type Segmentation (2017 to 2021f)
        4.2.1 Scopolamine Butylbromide
        4.2.2 Scopolamine Hydrobromide
        4.2.3 Others
    4.3 Consumption Segmentation (2017 to 2021f)
        4.3.1 Oral
        4.3.2 Injection
        4.3.3 Patches
5  NORTH AMERICA MARKET SEGMENT
    5.1 Region Segmentation (2017 to 2021f)
        5.1.1 U.S.
        5.1.2 Canada
        5.1.3 Mexico
    5.2 Product Type Segmentation (2017 to 2021f)
        5.2.1 Scopolamine Butylbromide
        5.2.2 Scopolamine Hydrobromide
        5.2.3 Others
    5.3 Consumption Segmentation (2017 to 2021f)
        5.3.1 Oral
        5.3.2 Injection
        5.3.3 Patches
    5.4 Impact of COVID-19 in North America
6  EUROPE MARKET SEGMENTATION
    6.1 Region Segmentation (2017 to 2021f)
        6.1.1 Germany
        6.1.2 UK
        6.1.3 France
        6.1.4 Italy
        6.1.5 Rest of Europe
    6.2 Product Type Segmentation (2017 to 2021f)
        6.2.1 Scopolamine Butylbromide
        6.2.2 Scopolamine Hydrobromide
        6.2.3 Others
    6.3 Consumption Segmentation (2017 to 2021f)
        6.3.1 Oral
        6.3.2 Injection
        6.3.3 Patches
    6.4  Impact of COVID-19 in Europe
7  ASIA-PACIFIC MARKET SEGMENTATION
    7.1 Region Segmentation (2017 to 2021f)
        7.1.1 China
        7.1.2 India
        7.1.3 Japan
        7.1.4 South Korea
        7.1.5 Southeast Asia
        7.1.6 Australia
        7.1.7 Rest of Asia Pacific
    7.2 Product Type Segmentation (2017 to 2021f)
        7.2.1 Scopolamine Butylbromide
        7.2.2 Scopolamine Hydrobromide
        7.2.3 Others
    7.3 Consumption Segmentation (2017 to 2021f)
        7.3.1 Oral
        7.3.2 Injection
        7.3.3 Patches
    7.4  Impact of COVID-19 in Europe
8  SOUTH AMERICA MARKET SEGMENTATION
    8.1 Region Segmentation (2017 to 2021f)
        8.1.1 Brazil
        8.1.2 Argentina
        8.1.3 Rest of Latin America
    8.2 Product Type Segmentation (2017 to 2021f)
        8.2.1 Scopolamine Butylbromide
        8.2.2 Scopolamine Hydrobromide
        8.2.3 Others
    8.3 Consumption Segmentation (2017 to 2021f)
        8.3.1 Oral
        8.3.2 Injection
        8.3.3 Patches
    8.4  Impact of COVID-19 in Europe
9  MIDDLE EAST AND AFRICA MARKET SEGMENTATION
    9.1 Region Segmentation (2017 to 2021f)
        9.1.1 GCC
        9.1.2 North Africa
        9.1.3 South Africa
        9.1.4 Rest of Middle East and Africa
    9.2 Product Type Segmentation (2017 to 2021f)
        9.2.1 Scopolamine Butylbromide
        9.2.2 Scopolamine Hydrobromide
        9.2.3 Others
    9.3 Consumption Segmentation (2017 to 2021f)
        9.3.1 Oral
        9.3.2 Injection
        9.3.3 Patches
    9.4  Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
    10.1 Brief Introduction of Major Players
        10.1.1 Alkaloids of Australia
        10.1.2 Centroflora-cms
        10.1.3 Fine Chemicals Corporation
        10.1.4 Phytex Australia
        10.1.5 Alchem International
        10.1.6 Guangzhou Hanfang
        10.1.7 Alkaloids Corporation
        10.1.8 Luyin
    10.2  Running Shoes Sales Date of Major Players (2017-2020e)
        10.2.1 Alkaloids of Australia
        10.2.2 Centroflora-cms
        10.2.3 Fine Chemicals Corporation
        10.2.4 Phytex Australia
        10.2.5 Alchem International
        10.2.6 Guangzhou Hanfang
        10.2.7 Alkaloids Corporation
        10.2.8 Luyin
    10.3  Market Distribution of Major Players
    10.4 Global Competition Segmentation
11  MARKET FORECAST
    11.1  Forecast by Region
    11.2  Forecast by Demand
    11.3  Environment Forecast
        11.3.1  Impact of COVID-19
        11.3.2  Geopolitics Overview
        11.3.3  Economic Overview of Major Countries
12  REPORT SUMMARY STATEMENT
List of Table
1.Table Running Shoes Product Type Overview
2.Table Running Shoes Product Type Market Share List
3.Table Running Shoes Product Type of Major Players
4.Table Brief Introduction of Alkaloids of Australia
5.Table Brief Introduction of Centroflora-cms
6.Table Brief Introduction of Fine Chemicals Corporation
7.Table Brief Introduction of Phytex Australia
8.Table Brief Introduction of Alchem International
9.Table Brief Introduction of Guangzhou Hanfang
10.Table Brief Introduction of Alkaloids Corporation
11.Table Brief Introduction of Luyin
12.Table Products & Services of Alkaloids of Australia
13.Table Products & Services of Centroflora-cms
14.Table Products & Services of Fine Chemicals Corporation
15.Table Products & Services of Phytex Australia
16.Table Products & Services of Alchem International
17.Table Products & Services of Guangzhou Hanfang
18.Table Products & Services of Alkaloids Corporation
19.Table Products & Services of Luyin
20.Table Market Distribution of Major Players
21.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
22.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
23.Table Global Running Shoes Market Forecast (Million USD) by Region 2021f-2026f
24.Table Global Running Shoes Market Forecast (Million USD) Share by Region 2021f-2026f
25.Table Global Running Shoes Market Forecast (Million USD) by Demand 2021f-2026f
26.Table Global Running Shoes Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global Running Shoes Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Running Shoes Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Running Shoes Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Running Shoes Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Running Shoes Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Running Shoes Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Running Shoes Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Scopolamine Butylbromide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Scopolamine Hydrobromide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Scopolamine Butylbromide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Scopolamine Hydrobromide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Scopolamine Butylbromide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Scopolamine Hydrobromide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Scopolamine Butylbromide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Scopolamine Hydrobromide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Scopolamine Butylbromide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Scopolamine Hydrobromide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Scopolamine Butylbromide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Scopolamine Hydrobromide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Patches Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Running Shoes Sales Revenue (Million USD) of Alkaloids of Australia 2017-2020e
72.Figure Running Shoes Sales Revenue (Million USD) of Centroflora-cms 2017-2020e
73.Figure Running Shoes Sales Revenue (Million USD) of Fine Chemicals Corporation 2017-2020e
74.Figure Running Shoes Sales Revenue (Million USD) of Phytex Australia 2017-2020e
75.Figure Running Shoes Sales Revenue (Million USD) of Alchem International 2017-2020e
76.Figure Running Shoes Sales Revenue (Million USD) of Guangzhou Hanfang 2017-2020e
77.Figure Running Shoes Sale
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Running Shoes Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Running Shoes Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Running Shoes Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports